Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Gamida Cell
Woman and Man Max 99 years
Gamida Cell Ltd
Update Il y a 4 ans
Long term follow up for patients who have received NiCord/CordIn, stem cells from donated umbilical cord blood that were grown in a laboratory to expand their number
Describe the clinical outcomes of patients who have received a NiCord/CordIn transplantation Describir los resultados clínicos de los pacientes que hayan recibido un trasplante de NiCord/CordIn
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 12 years and 55 years
Gamida Cell
Update Il y a 4 ans
GAMIDA CELL ExCell : Essai de phase 2-3 évaluant l'efficacité et la tolérance d'une greffe de cellules de cordon ombilical amplifiées ex vivo (StemEx®), chez des patients ayant un cancer hématologique nécessitant un traitement myéloablatif. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Su...
Country
France
organs
Tout cancer hématologique
Specialty
Greffe
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Gamida Cell Ltd
Update Il y a 4 ans
Transplantation of CordIn, stem cells from donated umbilical cord blood that were grown in a laboratory to expand their number, in patients with a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule Greffe de Cordin, cellules souches obtenues avec le don de sang de cordon ombilical et cultivées en laboratoire pour augmenter le nombre, chez des patients atteints d'un défaut génétique qui entraîne une structure anormale de l'une des chaînes de globine de la molécule d'hémoglobine
Assess the acute toxicities associated with the infusion of CordIn, within 24 hours post-infusion Assess the proportion of patients with donor-derived engraftment at 42 days following transplantation...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gamida Cell Ltd
Update Il y a 4 ans
A multicenter trial of transplantation of NiCord, stem cells from donated umbilical cord blood that were grown in a laboratory to expand their number versus unmanipulated umbilical cord blood for patients with cancers of the blood and lymph Ensayo multicéntrico de trasplante de NiCord, células madre y progenitoras de sangre de cordón umbilical que fueron cultivadas en un laboratorio para ampliar su número, frente a sangre de cordón umbilical no manipulada en pacientes con cáncer en la sangre
The overall study objective is to compare the safety and efficacy of NiCord single ex-vivo expanded cord blood unit transplantation to unmanipulated cord blood unit transplantation in patients with he...
Country
None
organs
None
Specialty
None
unknown
More information